RADIOGLIC

Visão geral do produto

About RADIOGLIC

RADIOGLIC is a specialized diagnostic medicine used in the field of nuclear medicine. It is formulated as an injectable solution intended for professional clinical use. This product is strictly regulated and must be administered by qualified healthcare personnel within a controlled medical environment equipped for radiopharmaceutical handling. RADIOGLIC is designed to assist clinicians in obtaining high-quality diagnostic imaging, providing essential information for the evaluation of physiological processes in the human body.

Key Benefits & Uses

• Facilitates precise diagnostic imaging procedures.
• Assists in the clinical assessment of metabolic activity.
• Supports medical professionals in diagnostic decision-making processes.

Active Ingredient & Action

The active ingredient in RADIOGLIC is fludesoxiglicose 18f. This substance acts as a radiopharmaceutical diagnostic agent. Once administered, it distributes throughout the body and is utilized in positron emission tomography (PET) imaging to visualize areas of specific metabolic uptake. The radioactive decay of the 18f isotope allows for the detection and mapping of these areas by specialized imaging equipment.

Important Notes

RADIOGLIC is intended solely for diagnostic purposes and is not a therapeutic treatment for any disease. It must be stored and handled according to strict radiation safety protocols. Patients should consult with their referring physician or nuclear medicine specialist regarding the specific requirements and safety considerations associated with their diagnostic procedure.